Silymarin in NAFLD

NCT02973295 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor withdrawn their agreement

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DRUG: Silymarin
OTHER: Placebo Oral Capsule

Sponsor

University Hospital Rijeka

Collaborators

[object Object]
[object Object]
[object Object]